Table 3 Survival of target tumor MDA/MB-361 cells incubated with healthy controls PBMC in nutrient medium with 10% pooled serum (Nc) or with 10% of autologous serum (Na) without or with 21 μg/ml Herceptin (Na+H). Effectors (E) to target tumor cells (T) ratio was 5:1.
From: The antitumor immune response in HER-2 positive, metastatic breast cancer patients
Control | S Nc (%) | S Na (%) | S Na+H (%) | CD16 (%) |
|---|---|---|---|---|
1 | ND | 103 | 49 | 15.00 |
2 | ND | 52 | 24 | 14.20 |
3 | ND | 73 | 55 | 10.00 |
4 | ND | 92 | 35 | 35.45 |
5 | ND | 66 | 17 | ND |
6 | ND | 22 | 26 | ND |
7 | ND | 89 | 58 | ND |
8 | 105 | 85 | 85 | ND |
9 | 58 | 85 | 49 | 17.55 |
10 | 74 | 82 | 34 | 16.15 |
11 | 20 | 27 | 0 | 16.45 |
12 | 93 | 92 | 24 | ND |
13 | 34 | 0 | 0 | 8.98 |
14 | 40 | 26 | 26 | 12.48 |
15 | 40 | 30 | 21 | 9.49 |
16 | 29 | 25 | 26 | 4.62 |
17 | 46 | 25 | 22 | 9.49 |
18 | 53 | 8.8 | 7 | 32.19 |
19 | 74 | 29 | 13 | 13.2 |
20 | 47 | 16 | 10 | 34.58 |